3/A//SEC Filing
Sofinnova HealthQuest Partners, L.P. 3/A
Accession 0001144204-19-036330
CIK 0001447362other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 8:48 PM ET
Size
14.6 KB
Accession
0001144204-19-036330
Insider Transaction Report
Form 3/AAmended
Holdings
Series A Preferred Stock
→ Common Stock (16,015 underlying)Series F Preferred Stock
→ Common Stock (982,785 underlying)Series F Preferred Stock Warrant (right to buy)
Exercise: $0.01From: 2018-01-12Exp: 2023-01-12→ Common Stock (11,572 underlying)Series E-2 Preferred Stock
→ Common Stock (358,416 underlying)Series E-3 Preferred Stock
→ Common Stock (318,842 underlying)Convertible Promissory Note
→ Common Stock
Kong Garheng
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (16,015 underlying)Series F Preferred Stock
→ Common Stock (982,785 underlying)Series E-2 Preferred Stock
→ Common Stock (358,416 underlying)Series E-3 Preferred Stock
→ Common Stock (318,842 underlying)Series F Preferred Stock Warrant (right to buy)
Exercise: $0.01From: 2018-01-12Exp: 2023-01-12→ Common Stock (11,572 underlying)Convertible Promissory Note
→ Common Stock
Sofinnova HealthQuest Partners, L.P.
10% Owner
Holdings
Series A Preferred Stock
→ Common Stock (16,015 underlying)Series E-2 Preferred Stock
→ Common Stock (358,416 underlying)Series E-3 Preferred Stock
→ Common Stock (318,842 underlying)Series F Preferred Stock
→ Common Stock (982,785 underlying)Series F Preferred Stock Warrant (right to buy)
Exercise: $0.01From: 2018-01-12Exp: 2023-01-12→ Common Stock (11,572 underlying)Convertible Promissory Note
→ Common Stock
Footnotes (3)
- [F1]All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration at a rate of one share of Common Stock for each 1.219 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.
- [F2]The principal amount of the Convertible Promissory Note held by the designated Reporting Person is $1,027,882. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the "Conversion Amount") will automatically convert into the number of shares of Common Stock that is equal to the Conversion Amount as of the closing date divided by 80% of the IPO price per share.
- [F3]The shares are directly held by Sofinnova HealthQuest Partners, L.P. ("HealthQuest"). HealthQuest Venture Management, L.L.C. ("HQVM"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein.
Documents
Issuer
CASTLE BIOSCIENCES INC
CIK 0001447362
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001579382
Filing Metadata
- Form type
- 3/A
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 8:48 PM ET
- Size
- 14.6 KB